Bayesian Adaptive Design for Clinical Trials in Duchenne Muscular Dystrophy

被引：0
|
作者：
Lake, Stephen [1 ]
机构：
[1] Wave Life Sci Ltd, Cambridge, MA 02138 USA
来源：
STATISTICS IN MEDICINE | 2022年 / 41卷 / 09期
关键词：
D O I：
10.1002/sim.9378
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1733 / 1734
页数：2
相关论文
共 50 条
  • [21] Duchenne Muscular Dystrophy clinical presentation
    Cammarata-Scalisi, Francisco
    Camacho, Nolis
    Alvarado, Jorge
    Angelina Lacruz-Rengel, Maria
    [J]. REVISTA CHILENA DE PEDIATRIA-CHILE, 2008, 79 (05): : 495 - 501
  • [22] The Bayesian Design of Adaptive Clinical Trials
    Giovagnoli, Alessandra
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (02) : 1 - 15
  • [23] Standardizing Ultrasound Assessment and Quantification for Use in Duchenne Muscular Dystrophy Clinical Trials
    Wilder, Sarah
    Zaidman, Craig
    Wu, Jim
    Darras, Basil
    Rutkove, Seward
    [J]. NEUROLOGY, 2013, 80
  • [24] Establishing the parameters for clinical trials of antisense oligonucleotide therapy in Duchenne muscular dystrophy
    Kinali, M.
    Arechavala-Omeza, V.
    Feng, L.
    Glover, A.
    Guglieri, M.
    Jungbluth, H.
    Roper, H.
    Quinlivan, R. M.
    Hunt, D.
    Marizur, A. M.
    Henderson, A.
    Gosalakkal, J.
    Hollingsworth, K.
    Allsop, J.
    Mercuri, E.
    Morgan, J.
    Sewry, C.
    Straub, V.
    Bushby, K.
    Rutherford, M.
    Muntoni, F.
    [J]. NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 773 - 773
  • [25] Review of Phase II and Phase III clinical trials for Duchenne muscular dystrophy
    Scully, Michele A.
    Pandya, Shree
    Moxley, Richard T.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (01): : 33 - 46
  • [26] Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
    Arechavala-Gomeza, Virginia
    Kinali, Maria
    Feng, Lucy
    Guglieri, Michela
    Edge, Geraldine
    Main, Marion
    Hunt, David
    Lehovsky, Jan
    Straub, Volker
    Bushby, Kate
    Sewry, Caroline A.
    Morgan, Jennifer E.
    Muntoni, Francesco
    [J]. NEUROMUSCULAR DISORDERS, 2010, 20 (05) : 295 - 301
  • [27] Standardizing Ultrasound Assessment and Quantification for Use in Duchenne Muscular Dystrophy Clinical Trials
    Wilder, Sarah
    Zaidman, Craig
    Wu, Jim
    Darras, Basil
    Rutkove, Seward
    [J]. NEUROLOGY, 2013, 80
  • [28] Perceived barriers and facilitators of participation in clinical trials for Duchenne and Becker muscular dystrophy
    Peay, H. L.
    Scharff, H.
    Biesecker, B. B.
    Wilfond, B. S.
    Johnson, J.
    Escolar, D. M.
    Bowie, J.
    Nagaraju, K.
    Piacentino, J.
    Tibben, A.
    [J]. NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 912 - 912
  • [29] Muscle biopsies in clinical trials for Duchenne muscular dystrophy - patients' and caregivers' perspective
    Verhaart, J.
    Johnson, A.
    Thakrar, S.
    Vroom, E.
    De Angelis, E.
    Muntoni, F.
    Aartsma-Rus, A.
    Niks, E.
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 : S91 - S91
  • [30] Duchenne muscular dystrophy: promising early-stage clinical trials to watch
    Tang, Annie
    Yokota, Toshifumi
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (03) : 201 - 217
12345